The DPYD gene encodes a protein that is active in the catabolic pathway of 5-fluorouracil and DPYD mutations result in an increased risk of toxicity in cancer patients receiving 5-fluorouracil chemotherapy (64). The gene discussed is DPYD; the disease is cancer.